NM_005104.4:c.-1765G>A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_005104.4(BRD2):​c.-1765G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.118 in 152,992 control chromosomes in the GnomAD database, including 1,303 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.12 ( 1297 hom., cov: 33)
Exomes 𝑓: 0.12 ( 6 hom. )

Consequence

BRD2
NM_005104.4 5_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.109

Publications

19 publications found
Variant links:
Genes affected
BRD2 (HGNC:1103): (bromodomain containing 2) This gene encodes a transcriptional regulator that belongs to the BET (bromodomains and extra terminal domain) family of proteins. This protein associates with transcription complexes and with acetylated chromatin during mitosis, and it selectively binds to the acetylated lysine-12 residue of histone H4 via its two bromodomains. The gene maps to the major histocompatability complex (MHC) class II region on chromosome 6p21.3, but sequence comparison suggests that the protein is not involved in the immune response. This gene has been implicated in juvenile myoclonic epilepsy, a common form of epilepsy that becomes apparent in adolescence. Multiple alternatively spliced variants have been described for this gene. [provided by RefSeq, Dec 2010]
HLA-DMA (HGNC:4934): (major histocompatibility complex, class II, DM alpha) HLA-DMA belongs to the HLA class II alpha chain paralogues. This class II molecule is a heterodimer consisting of an alpha (DMA) and a beta chain (DMB), both anchored in the membrane. It is located in intracellular vesicles. DM plays a central role in the peptide loading of MHC class II molecules by helping to release the CLIP molecule from the peptide binding site. Class II molecules are expressed in antigen presenting cells (APC: B lymphocytes, dendritic cells, macrophages). The alpha chain is approximately 33-35 kDa and its gene contains 5 exons. Exon one encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, exon 4 encodes the transmembrane domain and the cytoplasmic tail. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.242 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BRD2NM_005104.4 linkc.-1765G>A 5_prime_UTR_variant Exon 1 of 13 ENST00000374825.9 NP_005095.1
LOC124901302NR_190903.1 linkn.-75C>T upstream_gene_variant
LOC124901302NR_190904.1 linkn.-75C>T upstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BRD2ENST00000374825.9 linkc.-1765G>A 5_prime_UTR_variant Exon 1 of 13 1 NM_005104.4 ENSP00000363958.4 P25440-1
HLA-DMAENST00000422832.1 linkc.-12+406C>T intron_variant Intron 1 of 2 6 ENSP00000403122.1 F6S093
HLA-DMAENST00000464392.1 linkn.-152C>T upstream_gene_variant 6

Frequencies

GnomAD3 genomes
AF:
0.118
AC:
17895
AN:
152096
Hom.:
1289
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0637
Gnomad AMI
AF:
0.190
Gnomad AMR
AF:
0.185
Gnomad ASJ
AF:
0.165
Gnomad EAS
AF:
0.254
Gnomad SAS
AF:
0.226
Gnomad FIN
AF:
0.101
Gnomad MID
AF:
0.130
Gnomad NFE
AF:
0.116
Gnomad OTH
AF:
0.128
GnomAD4 exome
AF:
0.125
AC:
97
AN:
778
Hom.:
6
Cov.:
0
AF XY:
0.112
AC XY:
67
AN XY:
598
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
10
American (AMR)
AF:
0.0833
AC:
1
AN:
12
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
6
East Asian (EAS)
AF:
0.188
AC:
3
AN:
16
South Asian (SAS)
AF:
0.188
AC:
15
AN:
80
European-Finnish (FIN)
AF:
0.0667
AC:
2
AN:
30
Middle Eastern (MID)
AF:
0.125
AC:
1
AN:
8
European-Non Finnish (NFE)
AF:
0.112
AC:
65
AN:
580
Other (OTH)
AF:
0.278
AC:
10
AN:
36
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
5
10
14
19
24
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.118
AC:
17900
AN:
152214
Hom.:
1297
Cov.:
33
AF XY:
0.121
AC XY:
8988
AN XY:
74426
show subpopulations
African (AFR)
AF:
0.0636
AC:
2642
AN:
41548
American (AMR)
AF:
0.185
AC:
2834
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.165
AC:
571
AN:
3470
East Asian (EAS)
AF:
0.253
AC:
1308
AN:
5160
South Asian (SAS)
AF:
0.225
AC:
1086
AN:
4830
European-Finnish (FIN)
AF:
0.101
AC:
1073
AN:
10618
Middle Eastern (MID)
AF:
0.129
AC:
38
AN:
294
European-Non Finnish (NFE)
AF:
0.116
AC:
7891
AN:
67972
Other (OTH)
AF:
0.134
AC:
284
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
837
1675
2512
3350
4187
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
208
416
624
832
1040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.115
Hom.:
2344
Bravo
AF:
0.119
Asia WGS
AF:
0.248
AC:
861
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
6.3
DANN
Benign
0.78
PhyloP100
0.11
PromoterAI
-0.10
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3918149; hg19: chr6-32936373; COSMIC: COSV66374648; API